Clinical Trial Update: Finding ED90 of Flumazenil for Selective Improvement of Respiratory Distress by Remimazolam [NA]

View source ↗

Summary

A completed Yonsei University trial aimed to identify the ED90 dose of flumazenil to selectively reverse respiratory distress associated with remimazolam. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Flumazenil (flumazenil)
• Remimazolam (remimazolam)

Snippet

Sponsor: Yonsei University | Conditions: Stomach Neoplasm | NA | Status: COMPLETED